title: Application of antisense oligodeoxynucleotides (ODNs) for the intervention of kidney disease. Antisense ODNs for transforming growth factor-beta-suppressed glomerulosclerosis in experimental glomerulonephritis.
authors: First Department of Medicine, Osaka University School of Medicine, Japan.
authors: E
authors: E
authors: Imai
authors: Y
authors: Y
authors: Isaka
authors: Y
authors: Y
authors: Akagi
authors: M
authors: M
authors: Arai
authors: T
authors: T
authors: Moriyama
authors: M
authors: M
authors: Takenaka
authors: T
authors: T
authors: Kaneko
authors: M
authors: M
authors: Horio
authors: A
authors: A
authors: Ando
authors: Y
authors: Y
authors: Orita
authors: Y
authors: Y
authors: Kaneda
authors: N
authors: N
authors: Ueda
authors: T
authors: T
authors: Kamada
mesh_terms: D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism; D005921:Glomerulonephritis / Q000188:drug therapy*; D006801:Humans; D007678:Kidney Glomerulus / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000378:metabolism / Q000627:therapeutic use*; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000032:analysis; D016212:Transforming Growth Factor beta / Q000235:genetics
chemical_list: D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta